11/4/2025

Oxacillin Sodium Injection

Products Affected - Description

- Oxacillin powder for solution, Armas Pharmaceuticals, 2 gram, vial, 10 count, NDC 72485-0409-10
- Oxacillin powder for solution, Eugia US, 10 gram, bulk vial, 10 count, NDC 55150-0129-99
- Oxacillin powder for solution, Eugia US, 2 gram, vial, 10 count, NDC 55150-0128-24

Reason for the Shortage

- Armas states the shortage is due to scanning issues with the product.
- Baxter has 2 gram/50 mL frozen premixed bags available.
- Eugia did not provide a reason for the shortage.
- Fresenius Kabi has oxacillin injection available.

Available Products

- Oxacillin solution, Baxter, 2 gram, 50 mL frozen premixed bag, 24 count, NDC 00338-1015-41
- Oxacillin powder for solution, Fresenius Kabi, 1 gram, vial, 10 count, NDC 63323-0813-20
- Oxacillin powder for solution, Fresenius Kabi, 2 gram, vial, 10 count, NDC 63323-0812-20

Estimated Resupply Dates

- Armas has oxacillin 2 gram vials on back order and the company estimates a release date in early-November 2025.
- Eugia has oxacillin 2 gram vials and 10 gram bulk vials on back order and the company estimates release date of November 2025.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.